Breast Surgical OncologistDuke UniversityDurham, North Carolina, United States
P2. Nodal disease burden in patients with clinically node-positive breast cancer undergoing tailored axillary surgery with or without axillary dissection in the neoadjuvant and upfront surgery setting: preplanned TAXIS/OPBC-03 study
Thursday, March 5, 202610:39 AM - 10:46 AM MST
P3. Epigenetic alterations associated with increased tumor proliferation in patients with obesity and triple-negative breast cancer
Thursday, March 5, 202610:46 AM - 10:53 AM MST
PPS30. Expanding the utilization of upfront sentinel lymph node biopsy in clinically node positive patients with estrogen receptor positive breast cancer
Friday, March 6, 20263:40 PM - 4:10 PM MST
